Bloomberg Intelligence cover image

AMD Suffers Worst Rout Since 2018 on Disappointing Forecast

Bloomberg Intelligence

00:00

Eli Lilly's Strong Guidance Versus Novo Nordisk

Sam Fazeli contrasts Lilly's upbeat sales forecast and trial data versus Novo's caution and price-pressure concerns.

Play episode from 05:56
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app